Cigna Corporation (CI) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$281.98
Price Target
$328.00
Target Range
$300.00 — $375.00
Analyst Rating
Buy
Forward P/E9.3x
Trailing P/E12.7x
Forward PEG—
Implied Growth+27.4%
Median Target$330.00
Analyst Spread22.9%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$300
+6.4%
Consensus
$328
+16.3%
Bull Case
$375
+33.0%
Valuation Model TargetsConfidence: 65/100
Bear$286
Base$413
Bull$1208
CI Price Target Analysis
Updated May 7, 2026As of May 7, 2026, Cigna Corporation (CI) has a Wall Street consensus price target of $328.00, based on estimates from 39 covering analysts. With the stock currently trading at $281.98, this represents a potential upside of +16.3%. The company has a market capitalization of $74.35B.
Analyst price targets range from a low of $300.00 to a high of $375.00, representing a 23% spread in expectations. The median target of $330.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 32 analysts rating the stock as a Buy or Strong Buy,7 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, CI trades at a trailing P/E of 12.7x and forward P/E of 9.3x. Analysts expect EPS to grow +27.4% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $412.82, with bear and bull scenarios of $286.40 and $1208.19 respectively. Model confidence stands at 65/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+8.2%
Avg Forward P/E19.5x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 UNHUnitedHealth Group Incorporated | $333.4B | $367.28 | $385.43 | +4.9% | Buy | 20.1x | 52 |
 ELVElevance Health Inc. | $81.4B | $374.71 | $382.38 | +2.0% | Buy | 14.0x | 37 |
 CVSCVS Health Corporation | $111.3B | $86.86 | $95.20 | +9.6% | Buy | 12.1x | 41 |
 HUMHumana Inc. | $29.6B | $246.33 | $246.00 | -0.1% | Hold | 27.6x | 44 |
 CNCCentene Corporation | $27.3B | $55.31 | $51.00 | -7.8% | Buy | 16.4x | 43 |
 MOHMolina Healthcare, Inc. | $10.3B | $197.44 | $166.09 | -15.9% | Buy | 38.3x | 38 |
 ESNTEssent Group Ltd. | $6.0B | $61.41 | $69.33 | +12.9% | Buy | 8.7x | 19 |
 MCKMcKesson Corporation | $91.1B | $743.67 | $1006.50 | +35.3% | Buy | 19.1x | 31 |
 CAHCardinal Health, Inc. | $45.1B | $191.49 | $249.67 | +30.4% | Buy | 18.5x | 33 |
 HCSGHealthcare Services Group, Inc. | $1.6B | $22.07 | $24.50 | +11.0% | Hold | 20.6x | 15 |
Upside Potential Comparison
MCKCAHESNTHCSGCVSUNHELVHUMFull CI Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See CI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCI — Frequently Asked Questions
Quick answers to the most common questions about buying CI stock.
What is the CI stock price target for 2026?
Cigna Corporation (CI) has a consensus 12-month price target of $328, implying 16.3% upside from $281.98. The 39 analysts covering CI see moderate appreciation potential.
Is CI a buy, sell, or hold?
CI has a consensus rating of "Buy" based on 39 Wall Street analysts. The rating breakdown is predominantly bullish, with 32 Buy/Strong Buy ratings. The consensus 12-month price target of $328 implies 16.3% upside from current levels.
Is CI stock overvalued or undervalued?
With a forward P/E of 9.2967x, CI trades at a relatively low valuation. The consensus target of $328 implies 16.3% appreciation, suggesting meaningful undervaluation.
How high can CI stock go?
The most bullish Wall Street analyst has a price target of $375 for CI, while the most conservative target is $300. The consensus of $328 represents the median expectation. Our quantitative valuation model projects a bull case target of $1208 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover CI stock?
CI is heavily covered by Wall Street, with 39 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 31 have Buy ratings, 7 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the CI stock forecast?
The 12-month CI stock forecast based on 39 Wall Street analysts shows a consensus price target of $328, with estimates ranging from $300 (bear case) to $375 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $413, with bear/bull scenarios of $286/$1208.
What is CI's fair value based on fundamentals?
Our quantitative valuation model calculates CI's fair value at $413 (base case), with a bear case of $286 and bull case of $1208. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 65/100.
What is CI's forward P/E ratio?
CI trades at a forward P/E ratio of 9.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 12.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy CI stock?
Wall Street analysts are optimistic on CI, with a "Buy" consensus rating and $328 price target (16.3% upside). 32 of 39 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do CI price targets vary so much?
CI analyst price targets range from $300 to $375, a 23% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $328 consensus represents the middle ground. Our model's $286-$1208 range provides an independent fundamental perspective.